|
How many volunteers were present at the Congress? : |
about 2000 person |
|
Delegates from which countries presented in the congress? : |
USA, CANADA, AUSTRALIA, FRANCE, BELGIUM, INDIA, JAPAN, CHINA, ITALY,SOUTH AFRICA,... |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
SGO, ESGO, ASCO |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
yes, they asked "is ovarian cancer common in your country?" Do you neoadjuvant chemotherapy in advanced patients of ovarian cancer, or another medical oncologist does it? Have you any complication with neoadjuvant chemotherapy? |
|
If you met staff members, please list their full names & positions. : |
Prof, HACKER.
Prof, Giliam Thomas.
Prof,Abu Rostam |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
the wake up with professor program was new, and interesting. it was 15 round table arranged at 7 o'clock, with 15 professor, and various different titles. 10 participant sit and talk with one of the professor about their interest title. The hospitality was very simple as the bag of the congress and launch. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
I had to take airplane from Sydney to Melbourne, and Australian accommodation was very expensive. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
Latest studies about Gynecology Oncology from very huge group of countries was presented, and I got lots of outcomes. There was very useful presentation about target therapy, in ovarian cancer. Professor Abu Rostam talked about sentinel node mapping in cervical cancer surgery and endometrial cancer. Professor Vergotte from Belgium talked about conditions of selected patient for primary debulking or neoadjuvant chemothrapy in advanced ovarian cancer. In workshop with title innovation in medical imaging Dr. C.Shadbolt from Australia talked about using MRI in gynecology and oncology and benefit of this kind of imaging camper to ultrasonography. |